"New visitation guidelines: Effective March 11, visitation is restricted to two persons per patient at a time, and children under the age of 18 are not permitted. Visit our website to learn more. North Shore University Hospital in Manhasset is an award winning 806-bed teaching hospital that delivers advanced care in all medical specialties, including open-heart surgery, neurosurgery, orthopaedic surgery, urology and maternal-fetal medicine."

During the past decade, Northwell Health NCORP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 27 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health NCORP" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Gynecologic Oncology Group" with 2 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health NCORP" #1 collaborator was "NCIC Clinical Trials Group" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health NCORP" are "Acute Myeloid Leukemia" (4 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (4 trials), "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11" (4 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (3 trials) and "Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1" (3 trials). Many other conditions were trialed in "Northwell Health NCORP" in a lesser frequency.

Most popular intervention types in "Northwell Health NCORP" are "Other" (27 trials), "Drug" (26 trials), "Biological" (15 trials), "Procedure" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (12 trials), "Paclitaxel" (8 trials), "Carboplatin" (5 trials) and "Pharmacological Study" (5 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health NCORP" are 19 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Northwell Health NCORP". undefined are not yet recruiting, undefined are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Northwell Health NCORP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health NCORP, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".